We are live on ! Find out more
GSK icon

GSK
GSK

919 hedge funds and large institutions have $14.4B invested in GSK in 2021 Q4 according to their latest regulatory filings, with 193 funds opening new positions, 321 increasing their positions, 247 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more first-time investments, than exits

New positions opened: 193 | Existing positions closed: 52

168% more call options, than puts

Call options by funds: $624M | Put options by funds: $233M

46% more funds holding in top 10

Funds holding in top 10: 13 → 19 (+6)

30% more repeat investments, than reductions

Existing positions increased: 321 | Existing positions reduced: 247

17% more capital invested

Capital invested by funds: $12.4B → $14.4B (+$2.04B)

16% more funds holding

Funds holding: 792 → 919 (+127)

0.07% more ownership

Funds ownership: 5.14% → 5.21% (+0.07%)

Holders
919
Holders Change
+127
Holders Change %
+16.04%
% of All Funds
14.14%
Holding in Top 10
19
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+46.15%
% of All Funds
0.29%
New
193
Increased
321
Reduced
247
Closed
52
Calls
$624M
Puts
$233M
Net Calls
+$391M
Net Calls Change
+$227M

Top Buyers

1
Nomura Holdings
Nomura Holdings
Japan
+$175M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$147M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$61.6M
4
Goldman Sachs
Goldman Sachs
New York
+$56.8M
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$54M

Top Sellers

1
UBS Group
UBS Group
Switzerland
-$253M
2
Capital International Investors
Capital International Investors
California
-$147M
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$101M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$88.8M
5
Two Sigma Investments
Two Sigma Investments
New York
-$63.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Dodge & Cox
1
Dodge & Cox
California
$3.9B +$20.9M +401,224 +0.6%
Capital International Investors
2
Capital International Investors
California
$843M -$147M -2,833,588 -16%
Fisher Asset Management
3
Fisher Asset Management
Washington
$803M +$16.1M +309,414 +2%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$783M +$19.9M +382,175 +3%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$667M +$14.2M +273,665 +2%
BCIM
6
Black Creek Investment Management
Ontario, Canada
$457M +$1.86M +35,675 +0.4%
Renaissance Technologies
7
Renaissance Technologies
New York
$451M +$33.7M +648,800 +9%
State Street
8
State Street
Massachusetts
$402M -$2.96M -56,847 -0.8%
Hotchkis & Wiley Capital Management
9
Hotchkis & Wiley Capital Management
California
$380M -$20.9M -401,857 -6%
Arrowstreet Capital
10
Arrowstreet Capital
Massachusetts
$320M +$147M +2,826,147 +95%
JEST
11
JTC Employer Solutions Trustee
Jersey
$264M -$13.8M -264,786 -5%
Capital Research Global Investors
12
Capital Research Global Investors
California
$246M -$31.4K -603 -0%
Goldman Sachs
13
Goldman Sachs
New York
$212M +$56.8M +1,092,320 +40%
Nomura Holdings
14
Nomura Holdings
Japan
$193M +$175M +3,356,637 +2,239%
Morgan Stanley
15
Morgan Stanley
New York
$190M +$2.02M +38,838 +1%
BNP Paribas Financial Markets
16
BNP Paribas Financial Markets
France
$171M -$88.8M -1,707,949 -36%
Wells Fargo
17
Wells Fargo
California
$159M +$2.92M +56,142 +2%
Bank of America
18
Bank of America
North Carolina
$137M -$20.7M -397,584 -14%
EIC
19
Equity Investment Corp
Georgia
$129M +$323K +6,201 +0.3%
PPA
20
Parametric Portfolio Associates
Washington
$119M +$13M +249,813 +13%
CCM
21
Camber Capital Management
Massachusetts
$110M -$10.4M -200,000 -9%
Macquarie Group
22
Macquarie Group
Australia
$110M -$8.87M -170,465 -8%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$103M +$146K +2,804 +0.2%
Northern Trust
24
Northern Trust
Illinois
$92M +$8.68M +166,854 +11%
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$91.7M -$5.39M -103,603 -6%
1
2 3 4 5

GSK Hedge Fund Activity: Q4 2021 in Review

919 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q4 2021, worth a combined $14.4B — up 17% from $12.4B a quarter earlier.

Buyers outnumbered sellers: 193 funds opened new GSK positions and 52 closed out — a net gain of 141 holders — while 321 added to existing stakes and 247 trimmed.

The largest buyer was Nomura Holdings, adding an estimated $175M. The largest seller was UBS Group, cutting an estimated $253M.

  • 919 institutional investors held GSK (GSK) as of Q4 2021, up from 792 in Q3 2021.
  • Funds reported $14.4B of GSK stock for Q4 2021, up 17% quarter-over-quarter.
  • 193 funds opened new GSK positions in Q4 2021 and 52 closed out, a net change of +141 holders.
  • The largest GSK buyer in Q4 2021 was Nomura Holdings, an estimated $175M added.
  • The largest GSK seller in Q4 2021 was UBS Group, an estimated $253M sold.

Based on aggregated 13F filings for Q4 2021.